Shripad Upasani Named CEO of Parasnath Clinic, Targets INR 100 Cr Turnover by FY 2025-26

Navi Mumbai (Maharashtra) [India], March 27: Parasnath Speciality Clinic, a leading healthcare provider focused on specialized medical treatments, is set to embark on an ambitious expansion journey under the leadership of Mr. Shripad Upasani. A seasoned business leader with over a decade of experience in driving organizational growth and sales excellence, Mr. Upasani has now taken the helm at Parasnath Speciality Clinic with a transformative vision.

Founded by Dr. Bhalchandra Mahamuni and Dr. Soniya Mahamuni, Parasnath Speciality Clinic has been a trusted name in non-surgical, holistic treatments for over 13 years. Now, with Mr. Shripad Upasani stepping in as Director and CEO, the organization is poised for a new era of expansion and innovation.

Having previously served as the CEO of Madhavbaug Heart and Diabetes Care Clinics and Hospitals and D.Y. Patil Vidyapeeth, Mr. Upasani played a pivotal role in scaling the organization from 103 clinics in 2 states to over 350 clinics across 12 states, leading to a remarkable revenue growth from ₹24 crore to ₹200 crore. He also spearheaded Madhavbaug’s transition into a publicly listed entity, solidifying its financial stability and long-term sustainability.

At Parasnath Speciality Clinic, he is now setting his sights on another transformative milestone: establishing 100 clinics by the next financial year and achieving ₹100 crore in turnover. The initial expansion phase will focus on Maharashtra, with a strategic plan to extend operations across Pan India. Additionally, the organization aims to treat 1.2 lakh patients, reinforcing its commitment to accessible and specialized healthcare solutions.

“Healthcare is not just about treatment—it’s about accessibility, trust, and long-term patient outcomes. At Parasnath Speciality Clinic, our vision is to redefine specialty care by expanding our reach while maintaining a strong focus on quality and innovation. With an ambitious roadmap ahead, I look forward to driving impactful change with our whole team and making a difference in countless lives,” said Mr. Shripad.

With his proven expertise in scaling businesses, fostering high-performance teams, and executing sustainable growth strategies, Parasnath Speciality Clinic is all set to enter a new era of healthcare excellence.

About Parasnath Speciality Clinic

In India, the prevalence of joint pain and musculoskeletal disorders is skyrocketing, affecting over 210 million people, with knee osteoarthritis alone impacting nearly 15% of the adult population. With a rapidly aging demographic and increasing lifestyle-induced ailments, the demand for specialized, non-surgical pain management solutions has never been higher. According to the Indian Journal of Orthopaedics, cases of osteoarthritis are expected to double by 2030, emphasizing the urgent need for holistic and long-term relief methods.

For a decade, Parasnath Speciality Clinic has been at the forefront of researching and developing highly effective treatment protocols, blending modern science with ancient wisdom. Operating across various parts of Maharashtra, the clinic has successfully benefited over 2 lakh patients, delivering customized, non-surgical, and holistic healing solutions.

With 11 clinics already operational, Parasnath Speciality Clinic provides relief to over 5,000 patients monthly. It specializes in joint pain management through a unique blend of therapies that purify the body and restore joint vitality. The clinic also offers specialized treatments for Sciatica, Spine, Knee, Arthritis, Gout, and Rheumatism.

The clinic’s core philosophy is built around:

  • Non-Surgical & Steroid-Free Treatments

  • Holistic & Customized Healing Approaches

  • Root-Cause Diagnosis & Long-Term Relief

With scientifically backed protocols and a vision to make specialty healthcare more accessible, Parasnath Speciality Clinic is committed to transforming lives through evidence-based, natural healing techniques.

For more information, please visit: https://parasnathclinics.com/

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Business Cast Iron Ductile Iron components H1 FY26 KVS Castings Limited KVSCASTING manufacturer of high-quality ferrous castings results

KVS Castings Limited Reports Steady H1 FY26 Result – Revenue at INR 2,390.61 Lakhs | EBITDA Up 40.99% YoY | PAT Rises 42.52% YoY

Kashipur (Uttarakhand) [India], November 17: KVS Castings Limited (BSE SME: KVSCASTING | INE163701019), a leading manufacturer of high-quality ferrous castings specialising in Cast Iron and Ductile Iron components, has announced its unaudited financial results for H1 FY26.  H1 FY26 Key Financial Highlights Particulars (₹ In Lakhs) H1 FY26 H1 FY25 YoY Change Revenue from Operations 2,390.61 2,317.15 3.17% EBITDA 549.21 389.53 40.99% EBITDA Margin 22.97% 16.81% 616.29 BPS PAT […]

Read More
Business Gear Shaping H1 FY26 Heavy Machining High Pressure Die Casting Induction Hardening and Gas Nitriding Precision Machining of Ferrous and Non-Ferrous Mat Thaai Casting Limited

Thaai Casting Limited Records INR 62.25 Crore Consolidated Revenue in H1 FY26 with 16% YoY Growth

Chennai (Tamil Nadu) [India], November 17:  Thaai Casting Limited (NSE Emerge: TCL | INE0QJL01014), specialising in High Pressure Die Casting (HPDC), Induction Hardening and Gas Nitriding, Precision Machining of Ferrous and Non-Ferrous Materials, Gear Shaping, and Heavy Machining, has announced its unaudited financial results for H1 FY26. Standalone Key Financial Highlights Particulars (₹ In Crore) H1 FY26 H1 FY25 […]

Read More
Business Globe Civil Projects Limited

Globe Civil Projects Limited Reports Strong Q2 & H1 FY26 Results; Total Income Jumps 40 Percent QoQ

New Delhi [India], November 17: Globe Civil Projects Limited (NSE: GLOBECIVIL / BSE: 544424), an integrated EPC company with over two decades of experience in delivering large-scale institutional, public infrastructure and commercial development projects, announced its Unaudited Financial Results for the Quarter and Half Year ended September 30, 2025. Key Consolidated Financial Highlights – Q2 & H1 FY2025-26  (In […]

Read More